China Pharma Holdings Inc Sustainability Reports
China Pharma Holdings Inc. develops, manufactures, and markets pharmaceutical products primarily for the treatment of cardiovascular and central nervous system diseases in China.
Sector: Health Care
Country: China
Exchange: NYSE American
ISIN: US16941T2033
3 reports from 2019 to 2023
Company Profile
China Pharma Holdings Inc
China Pharma Holdings Inc. develops, manufactures, and markets pharmaceutical products primarily for the treatment of cardiovascular and central nervous system diseases in China.
Reports